Global Oral Insulin Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoidance of peripheral hyperinsulinemia and other adverse effects such as possible hypoglycemia and weight gain.
LPI (LP Information)' newest research report, the “Oral Insulin Industry Forecast” looks at past sales and reviews total world Oral Insulin sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral Insulin sales for 2023 through 2029. With Oral Insulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Insulin industry.
This Insight Report provides a comprehensive analysis of the global Oral Insulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Insulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oral Insulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Insulin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Insulin.
The global Oral Insulin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oral Insulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oral Insulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oral Insulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oral Insulin players cover Novo Nordisk, Oramed Pharmaceuticals, vTv Therapeutics, Diabetology, Generex Biotechnology, Coromed and Nektar Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Insulin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Oral Insulin market?
What factors are driving Oral Insulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Insulin market opportunities vary by end market size?
How does Oral Insulin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoidance of peripheral hyperinsulinemia and other adverse effects such as possible hypoglycemia and weight gain.
LPI (LP Information)' newest research report, the “Oral Insulin Industry Forecast” looks at past sales and reviews total world Oral Insulin sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral Insulin sales for 2023 through 2029. With Oral Insulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Insulin industry.
This Insight Report provides a comprehensive analysis of the global Oral Insulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Insulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oral Insulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Insulin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Insulin.
The global Oral Insulin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oral Insulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oral Insulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oral Insulin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oral Insulin players cover Novo Nordisk, Oramed Pharmaceuticals, vTv Therapeutics, Diabetology, Generex Biotechnology, Coromed and Nektar Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Insulin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Type 1 Diabetes
- Type 2 Diabetes
- Female
- Male
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- Oramed Pharmaceuticals
- vTv Therapeutics
- Diabetology
- Generex Biotechnology
- Coromed
- Nektar Therapeutics
What is the 10-year outlook for the global Oral Insulin market?
What factors are driving Oral Insulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Insulin market opportunities vary by end market size?
How does Oral Insulin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Insulin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Oral Insulin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Oral Insulin by Country/Region, 2018, 2022 & 2029
2.2 Oral Insulin Segment by Type
2.2.1 Type 1 Diabetes
2.2.2 Type 2 Diabetes
2.3 Oral Insulin Sales by Type
2.3.1 Global Oral Insulin Sales Market Share by Type (2018-2023)
2.3.2 Global Oral Insulin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Oral Insulin Sale Price by Type (2018-2023)
2.4 Oral Insulin Segment by Application
2.4.1 Female
2.4.2 Male
2.5 Oral Insulin Sales by Application
2.5.1 Global Oral Insulin Sale Market Share by Application (2018-2023)
2.5.2 Global Oral Insulin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Oral Insulin Sale Price by Application (2018-2023)
3 GLOBAL ORAL INSULIN BY COMPANY
3.1 Global Oral Insulin Breakdown Data by Company
3.1.1 Global Oral Insulin Annual Sales by Company (2018-2023)
3.1.2 Global Oral Insulin Sales Market Share by Company (2018-2023)
3.2 Global Oral Insulin Annual Revenue by Company (2018-2023)
3.2.1 Global Oral Insulin Revenue by Company (2018-2023)
3.2.2 Global Oral Insulin Revenue Market Share by Company (2018-2023)
3.3 Global Oral Insulin Sale Price by Company
3.4 Key Manufacturers Oral Insulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Insulin Product Location Distribution
3.4.2 Players Oral Insulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ORAL INSULIN BY GEOGRAPHIC REGION
4.1 World Historic Oral Insulin Market Size by Geographic Region (2018-2023)
4.1.1 Global Oral Insulin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Oral Insulin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oral Insulin Market Size by Country/Region (2018-2023)
4.2.1 Global Oral Insulin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Oral Insulin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oral Insulin Sales Growth
4.4 APAC Oral Insulin Sales Growth
4.5 Europe Oral Insulin Sales Growth
4.6 Middle East & Africa Oral Insulin Sales Growth
5 AMERICAS
5.1 Americas Oral Insulin Sales by Country
5.1.1 Americas Oral Insulin Sales by Country (2018-2023)
5.1.2 Americas Oral Insulin Revenue by Country (2018-2023)
5.2 Americas Oral Insulin Sales by Type
5.3 Americas Oral Insulin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Insulin Sales by Region
6.1.1 APAC Oral Insulin Sales by Region (2018-2023)
6.1.2 APAC Oral Insulin Revenue by Region (2018-2023)
6.2 APAC Oral Insulin Sales by Type
6.3 APAC Oral Insulin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Insulin by Country
7.1.1 Europe Oral Insulin Sales by Country (2018-2023)
7.1.2 Europe Oral Insulin Revenue by Country (2018-2023)
7.2 Europe Oral Insulin Sales by Type
7.3 Europe Oral Insulin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Insulin by Country
8.1.1 Middle East & Africa Oral Insulin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Oral Insulin Revenue by Country (2018-2023)
8.2 Middle East & Africa Oral Insulin Sales by Type
8.3 Middle East & Africa Oral Insulin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Insulin
10.3 Manufacturing Process Analysis of Oral Insulin
10.4 Industry Chain Structure of Oral Insulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Insulin Distributors
11.3 Oral Insulin Customer
12 WORLD FORECAST REVIEW FOR ORAL INSULIN BY GEOGRAPHIC REGION
12.1 Global Oral Insulin Market Size Forecast by Region
12.1.1 Global Oral Insulin Forecast by Region (2024-2029)
12.1.2 Global Oral Insulin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Insulin Forecast by Type
12.7 Global Oral Insulin Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Oral Insulin Product Portfolios and Specifications
13.1.3 Novo Nordisk Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Oramed Pharmaceuticals
13.2.1 Oramed Pharmaceuticals Company Information
13.2.2 Oramed Pharmaceuticals Oral Insulin Product Portfolios and Specifications
13.2.3 Oramed Pharmaceuticals Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Oramed Pharmaceuticals Main Business Overview
13.2.5 Oramed Pharmaceuticals Latest Developments
13.3 vTv Therapeutics
13.3.1 vTv Therapeutics Company Information
13.3.2 vTv Therapeutics Oral Insulin Product Portfolios and Specifications
13.3.3 vTv Therapeutics Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 vTv Therapeutics Main Business Overview
13.3.5 vTv Therapeutics Latest Developments
13.4 Diabetology
13.4.1 Diabetology Company Information
13.4.2 Diabetology Oral Insulin Product Portfolios and Specifications
13.4.3 Diabetology Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Diabetology Main Business Overview
13.4.5 Diabetology Latest Developments
13.5 Generex Biotechnology
13.5.1 Generex Biotechnology Company Information
13.5.2 Generex Biotechnology Oral Insulin Product Portfolios and Specifications
13.5.3 Generex Biotechnology Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Generex Biotechnology Main Business Overview
13.5.5 Generex Biotechnology Latest Developments
13.6 Coromed
13.6.1 Coromed Company Information
13.6.2 Coromed Oral Insulin Product Portfolios and Specifications
13.6.3 Coromed Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Coromed Main Business Overview
13.6.5 Coromed Latest Developments
13.7 Nektar Therapeutics
13.7.1 Nektar Therapeutics Company Information
13.7.2 Nektar Therapeutics Oral Insulin Product Portfolios and Specifications
13.7.3 Nektar Therapeutics Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Nektar Therapeutics Main Business Overview
13.7.5 Nektar Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Insulin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Oral Insulin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Oral Insulin by Country/Region, 2018, 2022 & 2029
2.2 Oral Insulin Segment by Type
2.2.1 Type 1 Diabetes
2.2.2 Type 2 Diabetes
2.3 Oral Insulin Sales by Type
2.3.1 Global Oral Insulin Sales Market Share by Type (2018-2023)
2.3.2 Global Oral Insulin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Oral Insulin Sale Price by Type (2018-2023)
2.4 Oral Insulin Segment by Application
2.4.1 Female
2.4.2 Male
2.5 Oral Insulin Sales by Application
2.5.1 Global Oral Insulin Sale Market Share by Application (2018-2023)
2.5.2 Global Oral Insulin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Oral Insulin Sale Price by Application (2018-2023)
3 GLOBAL ORAL INSULIN BY COMPANY
3.1 Global Oral Insulin Breakdown Data by Company
3.1.1 Global Oral Insulin Annual Sales by Company (2018-2023)
3.1.2 Global Oral Insulin Sales Market Share by Company (2018-2023)
3.2 Global Oral Insulin Annual Revenue by Company (2018-2023)
3.2.1 Global Oral Insulin Revenue by Company (2018-2023)
3.2.2 Global Oral Insulin Revenue Market Share by Company (2018-2023)
3.3 Global Oral Insulin Sale Price by Company
3.4 Key Manufacturers Oral Insulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Insulin Product Location Distribution
3.4.2 Players Oral Insulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ORAL INSULIN BY GEOGRAPHIC REGION
4.1 World Historic Oral Insulin Market Size by Geographic Region (2018-2023)
4.1.1 Global Oral Insulin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Oral Insulin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oral Insulin Market Size by Country/Region (2018-2023)
4.2.1 Global Oral Insulin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Oral Insulin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oral Insulin Sales Growth
4.4 APAC Oral Insulin Sales Growth
4.5 Europe Oral Insulin Sales Growth
4.6 Middle East & Africa Oral Insulin Sales Growth
5 AMERICAS
5.1 Americas Oral Insulin Sales by Country
5.1.1 Americas Oral Insulin Sales by Country (2018-2023)
5.1.2 Americas Oral Insulin Revenue by Country (2018-2023)
5.2 Americas Oral Insulin Sales by Type
5.3 Americas Oral Insulin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Insulin Sales by Region
6.1.1 APAC Oral Insulin Sales by Region (2018-2023)
6.1.2 APAC Oral Insulin Revenue by Region (2018-2023)
6.2 APAC Oral Insulin Sales by Type
6.3 APAC Oral Insulin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Insulin by Country
7.1.1 Europe Oral Insulin Sales by Country (2018-2023)
7.1.2 Europe Oral Insulin Revenue by Country (2018-2023)
7.2 Europe Oral Insulin Sales by Type
7.3 Europe Oral Insulin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Insulin by Country
8.1.1 Middle East & Africa Oral Insulin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Oral Insulin Revenue by Country (2018-2023)
8.2 Middle East & Africa Oral Insulin Sales by Type
8.3 Middle East & Africa Oral Insulin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Insulin
10.3 Manufacturing Process Analysis of Oral Insulin
10.4 Industry Chain Structure of Oral Insulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Insulin Distributors
11.3 Oral Insulin Customer
12 WORLD FORECAST REVIEW FOR ORAL INSULIN BY GEOGRAPHIC REGION
12.1 Global Oral Insulin Market Size Forecast by Region
12.1.1 Global Oral Insulin Forecast by Region (2024-2029)
12.1.2 Global Oral Insulin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Insulin Forecast by Type
12.7 Global Oral Insulin Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Oral Insulin Product Portfolios and Specifications
13.1.3 Novo Nordisk Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Oramed Pharmaceuticals
13.2.1 Oramed Pharmaceuticals Company Information
13.2.2 Oramed Pharmaceuticals Oral Insulin Product Portfolios and Specifications
13.2.3 Oramed Pharmaceuticals Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Oramed Pharmaceuticals Main Business Overview
13.2.5 Oramed Pharmaceuticals Latest Developments
13.3 vTv Therapeutics
13.3.1 vTv Therapeutics Company Information
13.3.2 vTv Therapeutics Oral Insulin Product Portfolios and Specifications
13.3.3 vTv Therapeutics Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 vTv Therapeutics Main Business Overview
13.3.5 vTv Therapeutics Latest Developments
13.4 Diabetology
13.4.1 Diabetology Company Information
13.4.2 Diabetology Oral Insulin Product Portfolios and Specifications
13.4.3 Diabetology Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Diabetology Main Business Overview
13.4.5 Diabetology Latest Developments
13.5 Generex Biotechnology
13.5.1 Generex Biotechnology Company Information
13.5.2 Generex Biotechnology Oral Insulin Product Portfolios and Specifications
13.5.3 Generex Biotechnology Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Generex Biotechnology Main Business Overview
13.5.5 Generex Biotechnology Latest Developments
13.6 Coromed
13.6.1 Coromed Company Information
13.6.2 Coromed Oral Insulin Product Portfolios and Specifications
13.6.3 Coromed Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Coromed Main Business Overview
13.6.5 Coromed Latest Developments
13.7 Nektar Therapeutics
13.7.1 Nektar Therapeutics Company Information
13.7.2 Nektar Therapeutics Oral Insulin Product Portfolios and Specifications
13.7.3 Nektar Therapeutics Oral Insulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Nektar Therapeutics Main Business Overview
13.7.5 Nektar Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oral Insulin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oral Insulin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Type 1 Diabetes
Table 4. Major Players of Type 2 Diabetes
Table 5. Global Oral Insulin Sales by Type (2018-2023) & (K Units)
Table 6. Global Oral Insulin Sales Market Share by Type (2018-2023)
Table 7. Global Oral Insulin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Oral Insulin Revenue Market Share by Type (2018-2023)
Table 9. Global Oral Insulin Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Oral Insulin Sales by Application (2018-2023) & (K Units)
Table 11. Global Oral Insulin Sales Market Share by Application (2018-2023)
Table 12. Global Oral Insulin Revenue by Application (2018-2023)
Table 13. Global Oral Insulin Revenue Market Share by Application (2018-2023)
Table 14. Global Oral Insulin Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Oral Insulin Sales by Company (2018-2023) & (K Units)
Table 16. Global Oral Insulin Sales Market Share by Company (2018-2023)
Table 17. Global Oral Insulin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Oral Insulin Revenue Market Share by Company (2018-2023)
Table 19. Global Oral Insulin Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Oral Insulin Producing Area Distribution and Sales Area
Table 21. Players Oral Insulin Products Offered
Table 22. Oral Insulin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oral Insulin Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Oral Insulin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Oral Insulin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Oral Insulin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Oral Insulin Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Oral Insulin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Oral Insulin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Oral Insulin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Oral Insulin Sales by Country (2018-2023) & (K Units)
Table 34. Americas Oral Insulin Sales Market Share by Country (2018-2023)
Table 35. Americas Oral Insulin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Oral Insulin Revenue Market Share by Country (2018-2023)
Table 37. Americas Oral Insulin Sales by Type (2018-2023) & (K Units)
Table 38. Americas Oral Insulin Sales by Application (2018-2023) & (K Units)
Table 39. APAC Oral Insulin Sales by Region (2018-2023) & (K Units)
Table 40. APAC Oral Insulin Sales Market Share by Region (2018-2023)
Table 41. APAC Oral Insulin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Oral Insulin Revenue Market Share by Region (2018-2023)
Table 43. APAC Oral Insulin Sales by Type (2018-2023) & (K Units)
Table 44. APAC Oral Insulin Sales by Application (2018-2023) & (K Units)
Table 45. Europe Oral Insulin Sales by Country (2018-2023) & (K Units)
Table 46. Europe Oral Insulin Sales Market Share by Country (2018-2023)
Table 47. Europe Oral Insulin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Oral Insulin Revenue Market Share by Country (2018-2023)
Table 49. Europe Oral Insulin Sales by Type (2018-2023) & (K Units)
Table 50. Europe Oral Insulin Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Oral Insulin Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Oral Insulin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Oral Insulin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Oral Insulin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Oral Insulin Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Oral Insulin Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Oral Insulin
Table 58. Key Market Challenges & Risks of Oral Insulin
Table 59. Key Industry Trends of Oral Insulin
Table 60. Oral Insulin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Oral Insulin Distributors List
Table 63. Oral Insulin Customer List
Table 64. Global Oral Insulin Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Oral Insulin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Oral Insulin Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Oral Insulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Oral Insulin Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Oral Insulin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Oral Insulin Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Oral Insulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Oral Insulin Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Oral Insulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Oral Insulin Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Oral Insulin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Oral Insulin Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Oral Insulin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novo Nordisk Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 79. Novo Nordisk Oral Insulin Product Portfolios and Specifications
Table 80. Novo Nordisk Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Novo Nordisk Main Business
Table 82. Novo Nordisk Latest Developments
Table 83. Oramed Pharmaceuticals Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 84. Oramed Pharmaceuticals Oral Insulin Product Portfolios and Specifications
Table 85. Oramed Pharmaceuticals Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Oramed Pharmaceuticals Main Business
Table 87. Oramed Pharmaceuticals Latest Developments
Table 88. vTv Therapeutics Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 89. vTv Therapeutics Oral Insulin Product Portfolios and Specifications
Table 90. vTv Therapeutics Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. vTv Therapeutics Main Business
Table 92. vTv Therapeutics Latest Developments
Table 93. Diabetology Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 94. Diabetology Oral Insulin Product Portfolios and Specifications
Table 95. Diabetology Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Diabetology Main Business
Table 97. Diabetology Latest Developments
Table 98. Generex Biotechnology Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 99. Generex Biotechnology Oral Insulin Product Portfolios and Specifications
Table 100. Generex Biotechnology Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Generex Biotechnology Main Business
Table 102. Generex Biotechnology Latest Developments
Table 103. Coromed Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 104. Coromed Oral Insulin Product Portfolios and Specifications
Table 105. Coromed Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Coromed Main Business
Table 107. Coromed Latest Developments
Table 108. Nektar Therapeutics Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 109. Nektar Therapeutics Oral Insulin Product Portfolios and Specifications
Table 110. Nektar Therapeutics Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Nektar Therapeutics Main Business
Table 112. Nektar Therapeutics Latest Developments
Table 1. Oral Insulin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oral Insulin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Type 1 Diabetes
Table 4. Major Players of Type 2 Diabetes
Table 5. Global Oral Insulin Sales by Type (2018-2023) & (K Units)
Table 6. Global Oral Insulin Sales Market Share by Type (2018-2023)
Table 7. Global Oral Insulin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Oral Insulin Revenue Market Share by Type (2018-2023)
Table 9. Global Oral Insulin Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Oral Insulin Sales by Application (2018-2023) & (K Units)
Table 11. Global Oral Insulin Sales Market Share by Application (2018-2023)
Table 12. Global Oral Insulin Revenue by Application (2018-2023)
Table 13. Global Oral Insulin Revenue Market Share by Application (2018-2023)
Table 14. Global Oral Insulin Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Oral Insulin Sales by Company (2018-2023) & (K Units)
Table 16. Global Oral Insulin Sales Market Share by Company (2018-2023)
Table 17. Global Oral Insulin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Oral Insulin Revenue Market Share by Company (2018-2023)
Table 19. Global Oral Insulin Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Oral Insulin Producing Area Distribution and Sales Area
Table 21. Players Oral Insulin Products Offered
Table 22. Oral Insulin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oral Insulin Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Oral Insulin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Oral Insulin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Oral Insulin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Oral Insulin Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Oral Insulin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Oral Insulin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Oral Insulin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Oral Insulin Sales by Country (2018-2023) & (K Units)
Table 34. Americas Oral Insulin Sales Market Share by Country (2018-2023)
Table 35. Americas Oral Insulin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Oral Insulin Revenue Market Share by Country (2018-2023)
Table 37. Americas Oral Insulin Sales by Type (2018-2023) & (K Units)
Table 38. Americas Oral Insulin Sales by Application (2018-2023) & (K Units)
Table 39. APAC Oral Insulin Sales by Region (2018-2023) & (K Units)
Table 40. APAC Oral Insulin Sales Market Share by Region (2018-2023)
Table 41. APAC Oral Insulin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Oral Insulin Revenue Market Share by Region (2018-2023)
Table 43. APAC Oral Insulin Sales by Type (2018-2023) & (K Units)
Table 44. APAC Oral Insulin Sales by Application (2018-2023) & (K Units)
Table 45. Europe Oral Insulin Sales by Country (2018-2023) & (K Units)
Table 46. Europe Oral Insulin Sales Market Share by Country (2018-2023)
Table 47. Europe Oral Insulin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Oral Insulin Revenue Market Share by Country (2018-2023)
Table 49. Europe Oral Insulin Sales by Type (2018-2023) & (K Units)
Table 50. Europe Oral Insulin Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Oral Insulin Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Oral Insulin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Oral Insulin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Oral Insulin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Oral Insulin Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Oral Insulin Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Oral Insulin
Table 58. Key Market Challenges & Risks of Oral Insulin
Table 59. Key Industry Trends of Oral Insulin
Table 60. Oral Insulin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Oral Insulin Distributors List
Table 63. Oral Insulin Customer List
Table 64. Global Oral Insulin Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Oral Insulin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Oral Insulin Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Oral Insulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Oral Insulin Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Oral Insulin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Oral Insulin Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Oral Insulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Oral Insulin Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Oral Insulin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Oral Insulin Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Oral Insulin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Oral Insulin Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Oral Insulin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novo Nordisk Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 79. Novo Nordisk Oral Insulin Product Portfolios and Specifications
Table 80. Novo Nordisk Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Novo Nordisk Main Business
Table 82. Novo Nordisk Latest Developments
Table 83. Oramed Pharmaceuticals Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 84. Oramed Pharmaceuticals Oral Insulin Product Portfolios and Specifications
Table 85. Oramed Pharmaceuticals Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Oramed Pharmaceuticals Main Business
Table 87. Oramed Pharmaceuticals Latest Developments
Table 88. vTv Therapeutics Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 89. vTv Therapeutics Oral Insulin Product Portfolios and Specifications
Table 90. vTv Therapeutics Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. vTv Therapeutics Main Business
Table 92. vTv Therapeutics Latest Developments
Table 93. Diabetology Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 94. Diabetology Oral Insulin Product Portfolios and Specifications
Table 95. Diabetology Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Diabetology Main Business
Table 97. Diabetology Latest Developments
Table 98. Generex Biotechnology Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 99. Generex Biotechnology Oral Insulin Product Portfolios and Specifications
Table 100. Generex Biotechnology Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Generex Biotechnology Main Business
Table 102. Generex Biotechnology Latest Developments
Table 103. Coromed Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 104. Coromed Oral Insulin Product Portfolios and Specifications
Table 105. Coromed Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Coromed Main Business
Table 107. Coromed Latest Developments
Table 108. Nektar Therapeutics Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors
Table 109. Nektar Therapeutics Oral Insulin Product Portfolios and Specifications
Table 110. Nektar Therapeutics Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Nektar Therapeutics Main Business
Table 112. Nektar Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oral Insulin
Figure 2. Oral Insulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Insulin Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Oral Insulin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oral Insulin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Type 1 Diabetes
Figure 10. Product Picture of Type 2 Diabetes
Figure 11. Global Oral Insulin Sales Market Share by Type in 2022
Figure 12. Global Oral Insulin Revenue Market Share by Type (2018-2023)
Figure 13. Oral Insulin Consumed in Female
Figure 14. Global Oral Insulin Market: Female (2018-2023) & (K Units)
Figure 15. Oral Insulin Consumed in Male
Figure 16. Global Oral Insulin Market: Male (2018-2023) & (K Units)
Figure 17. Global Oral Insulin Sales Market Share by Application (2022)
Figure 18. Global Oral Insulin Revenue Market Share by Application in 2022
Figure 19. Oral Insulin Sales Market by Company in 2022 (K Units)
Figure 20. Global Oral Insulin Sales Market Share by Company in 2022
Figure 21. Oral Insulin Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Oral Insulin Revenue Market Share by Company in 2022
Figure 23. Global Oral Insulin Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Oral Insulin Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Oral Insulin Sales 2018-2023 (K Units)
Figure 26. Americas Oral Insulin Revenue 2018-2023 ($ Millions)
Figure 27. APAC Oral Insulin Sales 2018-2023 (K Units)
Figure 28. APAC Oral Insulin Revenue 2018-2023 ($ Millions)
Figure 29. Europe Oral Insulin Sales 2018-2023 (K Units)
Figure 30. Europe Oral Insulin Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Oral Insulin Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Oral Insulin Revenue 2018-2023 ($ Millions)
Figure 33. Americas Oral Insulin Sales Market Share by Country in 2022
Figure 34. Americas Oral Insulin Revenue Market Share by Country in 2022
Figure 35. Americas Oral Insulin Sales Market Share by Type (2018-2023)
Figure 36. Americas Oral Insulin Sales Market Share by Application (2018-2023)
Figure 37. United States Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Oral Insulin Sales Market Share by Region in 2022
Figure 42. APAC Oral Insulin Revenue Market Share by Regions in 2022
Figure 43. APAC Oral Insulin Sales Market Share by Type (2018-2023)
Figure 44. APAC Oral Insulin Sales Market Share by Application (2018-2023)
Figure 45. China Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Oral Insulin Sales Market Share by Country in 2022
Figure 53. Europe Oral Insulin Revenue Market Share by Country in 2022
Figure 54. Europe Oral Insulin Sales Market Share by Type (2018-2023)
Figure 55. Europe Oral Insulin Sales Market Share by Application (2018-2023)
Figure 56. Germany Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Oral Insulin Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Oral Insulin Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Oral Insulin Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Oral Insulin Sales Market Share by Application (2018-2023)
Figure 65. Egypt Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Oral Insulin in 2022
Figure 71. Manufacturing Process Analysis of Oral Insulin
Figure 72. Industry Chain Structure of Oral Insulin
Figure 73. Channels of Distribution
Figure 74. Global Oral Insulin Sales Market Forecast by Region (2024-2029)
Figure 75. Global Oral Insulin Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Oral Insulin Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Oral Insulin Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Oral Insulin Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Oral Insulin Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Oral Insulin
Figure 2. Oral Insulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Insulin Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Oral Insulin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oral Insulin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Type 1 Diabetes
Figure 10. Product Picture of Type 2 Diabetes
Figure 11. Global Oral Insulin Sales Market Share by Type in 2022
Figure 12. Global Oral Insulin Revenue Market Share by Type (2018-2023)
Figure 13. Oral Insulin Consumed in Female
Figure 14. Global Oral Insulin Market: Female (2018-2023) & (K Units)
Figure 15. Oral Insulin Consumed in Male
Figure 16. Global Oral Insulin Market: Male (2018-2023) & (K Units)
Figure 17. Global Oral Insulin Sales Market Share by Application (2022)
Figure 18. Global Oral Insulin Revenue Market Share by Application in 2022
Figure 19. Oral Insulin Sales Market by Company in 2022 (K Units)
Figure 20. Global Oral Insulin Sales Market Share by Company in 2022
Figure 21. Oral Insulin Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Oral Insulin Revenue Market Share by Company in 2022
Figure 23. Global Oral Insulin Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Oral Insulin Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Oral Insulin Sales 2018-2023 (K Units)
Figure 26. Americas Oral Insulin Revenue 2018-2023 ($ Millions)
Figure 27. APAC Oral Insulin Sales 2018-2023 (K Units)
Figure 28. APAC Oral Insulin Revenue 2018-2023 ($ Millions)
Figure 29. Europe Oral Insulin Sales 2018-2023 (K Units)
Figure 30. Europe Oral Insulin Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Oral Insulin Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Oral Insulin Revenue 2018-2023 ($ Millions)
Figure 33. Americas Oral Insulin Sales Market Share by Country in 2022
Figure 34. Americas Oral Insulin Revenue Market Share by Country in 2022
Figure 35. Americas Oral Insulin Sales Market Share by Type (2018-2023)
Figure 36. Americas Oral Insulin Sales Market Share by Application (2018-2023)
Figure 37. United States Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Oral Insulin Sales Market Share by Region in 2022
Figure 42. APAC Oral Insulin Revenue Market Share by Regions in 2022
Figure 43. APAC Oral Insulin Sales Market Share by Type (2018-2023)
Figure 44. APAC Oral Insulin Sales Market Share by Application (2018-2023)
Figure 45. China Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Oral Insulin Sales Market Share by Country in 2022
Figure 53. Europe Oral Insulin Revenue Market Share by Country in 2022
Figure 54. Europe Oral Insulin Sales Market Share by Type (2018-2023)
Figure 55. Europe Oral Insulin Sales Market Share by Application (2018-2023)
Figure 56. Germany Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Oral Insulin Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Oral Insulin Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Oral Insulin Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Oral Insulin Sales Market Share by Application (2018-2023)
Figure 65. Egypt Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Oral Insulin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Oral Insulin in 2022
Figure 71. Manufacturing Process Analysis of Oral Insulin
Figure 72. Industry Chain Structure of Oral Insulin
Figure 73. Channels of Distribution
Figure 74. Global Oral Insulin Sales Market Forecast by Region (2024-2029)
Figure 75. Global Oral Insulin Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Oral Insulin Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Oral Insulin Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Oral Insulin Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Oral Insulin Revenue Market Share Forecast by Application (2024-2029)
